Is Merck Stock a Buy?
Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader ...
Merck & Co. Inc. stock outperforms competitors on strong trading day
Shares of Merck & Co. Inc. MRK rallied 2.08% to $89.50 Friday, on what proved to be an all-around rough trading session for ...
Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently
We recently compiled a list of the 11 Most Expensive Stocks Insiders Are Buying Recently. In this article, we are going to ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class ...
GSK struggles to convince market it can deliver on pipeline plans
UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key patent expiry, as US hedge fund Citadel took the largest short position ...
Esperion Therapeutics: Little Upside Potential In Their Earlier Generation Drug
Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.
Healthcare sector takes the lead in 2025 as market volatility rises
The Healthcare sector of the economy is front and center on Friday as shares of UnitedHealth (UNH) drop 7.8%, spurring a widespread market selloff across the broader market averages. As UnitedHealth ...
devdiscourse19h
Trump's Stance on Drugmaker Production Could Impact Tariffs
Donald Trump has instructed pharmaceutical companies to relocate their production to the United States, warning they could ...